1. Liquid nitrogen-based cryoablation: complication rates for lung, bone, and soft tissue tumors cryoablation.
- Author
-
Orsi F, Hamiddin AS, Sattin C, Pizzi C, Varano GM, Della Vigna P, Mauri G, Maiettini D, and Bonomo G
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Adult, Retrospective Studies, Aged, 80 and over, Young Adult, Tomography, X-Ray Computed, Adolescent, Cryosurgery methods, Cryosurgery adverse effects, Bone Neoplasms surgery, Bone Neoplasms diagnostic imaging, Nitrogen therapeutic use, Lung Neoplasms surgery, Lung Neoplasms diagnostic imaging, Soft Tissue Neoplasms surgery, Soft Tissue Neoplasms diagnostic imaging, Postoperative Complications
- Abstract
Objective: This study aimed to assess the complication rate during and 24 hours after cryoablation in lung, bone, and soft tissue tumors., Methods: We reviewed complications in a total of 85 consecutive patients who underwent cryoablation using a liquid nitrogen-based system in various lesions between April 2017 and October 2022. There were no liver and renal lesions. Complications were categorized using the Society of Interventional Radiology classification., Results: Eighty-five patients were treated for 96 lesions in the bone (36.4%; 35 of 96), lung (18.8%; 18 of 96), and soft tissue (44.8%; 43 of 96). The primary technical success rate was 97.7% (83 of 85). The total grade 2 and 1 complication rates were 5.2% (5/96) and 20.8% (20/96), respectively. Two patients had asymptomatic pulmonary embolisms incidentally noted at the 24-hour follow-up computed tomography (grade 2). The most frequent complications were simple and hemorrhagic pleural effusions (18.7%; 18 of 96). Lung procedures had the highest complication rate, where 13 patients (72.2%; 13 of 18) reported complications, including 2 cases of symptomatic hydropneumothorax requiring drainage (grade 2) and an additional 2 days of hospital stay. Eight patients (24.2%; 8 of 33) with bone lesions and 4 (9.3%; 4 of 43) with soft tissue lesions experienced complications., Conclusion: Cryoablation using a liquid nitrogen-based system is safe, with only minor complications observed., Advances in Knowledge: This study provides data on the safety of liquid nitrogen-based percutaneous cryoablation in tumors located in lung, in bones and in soft tissues. Despite using larger diameter cryoprobes than those typically reported with argon-based system, our experience shows that complications are mostly low and comparable in frequency and severity., (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Institute of Radiology.)
- Published
- 2024
- Full Text
- View/download PDF